{"id":49236,"date":"2022-10-06T12:01:51","date_gmt":"2022-10-06T10:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/"},"modified":"2022-10-06T12:01:51","modified_gmt":"2022-10-06T10:01:51","slug":"us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/","title":{"rendered":"US Multiple Myeloma Market and Competitive Landscape &#8211; 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644694\/us-multiple-myeloma-market-and-competitive?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=lxstzd&amp;utm_campaign=1758851+-+US+Multiple+Myeloma+Market+and+Competitive+Landscape+-+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;US Multiple Myeloma Market and Competitive Landscape &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report US Multiple Myeloma Market and Competitive Landscape Highlights &#8211; 2022, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma drugs sales and competitive landscape in the US.\n<\/p>\n<p>\nThe research is classified into seven sections &#8211; Multiple Myeloma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.\n<\/p>\n<p>\n<strong>Research Scope:<\/strong>\n<\/p>\n<ul>\n<li>\nMultiple Myeloma pipeline: Find out the products in clinical trials for the treatment of Multiple Myeloma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products\n<\/li>\n<li>\nMultiple Myeloma epidemiology: Find out the number of patients diagnosed (prevalence) with Multiple Myeloma in the US\n<\/li>\n<li>\nMultiple Myeloma drugs: Identify key products marketed and prescribed for Multiple Myeloma in the US, including trade name, molecule name, and company\n<\/li>\n<li>\nMultiple Myeloma drugs sales: Find out the sales revenues of Multiple Myeloma drugs in the US\n<\/li>\n<li>\nMultiple Myeloma market valuations: Find out the market size for Multiple Myeloma drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027\n<\/li>\n<li>\nMultiple Myeloma drugs market share: Find out the market shares for key Multiple Myeloma drugs in the US\n<\/li>\n<\/ul>\n<p>\n<strong>Benefits of this Research:<\/strong>\n<\/p>\n<p>\nThe research helps executives to\n<\/p>\n<ul>\n<li>\nSupport monitoring and reporting national Multiple Myeloma market analysis and sales trends\n<\/li>\n<li>\nTrack competitor drugs sales and market share in the US Multiple Myeloma market\n<\/li>\n<li>\nTrack competitive developments in Multiple Myeloma market and present key issues and learnings\n<\/li>\n<li>\nSynthesize insights for Multiple Myeloma market and products to drive business performance\n<\/li>\n<li>\nAnswer key business questions about the Multiple Myeloma market\n<\/li>\n<li>\nEvaluate commercial market opportunity assessment, positioning, and segmentation for Multiple Myeloma products\n<\/li>\n<li>\nSupports decision making in R&amp;D to long term marketing strategies\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n1) Multiple Myeloma Treatments\n<\/p>\n<p>\n2) Multiple Myeloma Pipeline\n<\/p>\n<p>\n3) US Multiple Myeloma Epidemiology\n<\/p>\n<p>\n4) Marketed Drugs for Multiple Myeloma in US\n<\/p>\n<p>\n5) US Multiple Myeloma Market Size and Forecast\n<\/p>\n<p>\n6) US Multiple Myeloma Products Sales and Forecast\n<\/p>\n<p>\n7) US Multiple Myeloma Market Competitive Landscape\n<\/p>\n<p>\n8) Methodology\n<\/p>\n<p>\n9) Contact us\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644694\/us-multiple-myeloma-market-and-competitive?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=lxstzd&amp;utm_campaign=1758851+-+US+Multiple+Myeloma+Market+and+Competitive+Landscape+-+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/qddfom<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x70;&#114;&#101;s&#x73;&#x40;&#x72;&#101;&#115;e&#x61;&#x72;&#x63;&#104;&#97;n&#x64;&#x6d;&#x61;&#114;ke&#x74;&#x73;&#x2e;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#114;&#99;&#104;&#97;&#110;&#100;&#109;arkets&#x2e;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Multiple Myeloma Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report US Multiple Myeloma Market and Competitive Landscape Highlights &#8211; 2022, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma drugs sales and competitive landscape in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49236","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Multiple Myeloma Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report US Multiple Myeloma Market and Competitive Landscape Highlights &#8211; 2022, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma drugs sales and competitive landscape in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T10:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"US Multiple Myeloma Market and Competitive Landscape &#8211; 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-06T10:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/\"},\"wordCount\":420,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005454\\\/en\\\/1594125\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/\",\"name\":\"US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005454\\\/en\\\/1594125\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-06T10:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005454\\\/en\\\/1594125\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005454\\\/en\\\/1594125\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Multiple Myeloma Market and Competitive Landscape &#8211; 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Multiple Myeloma Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report US Multiple Myeloma Market and Competitive Landscape Highlights &#8211; 2022, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma drugs sales and competitive landscape in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-06T10:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"US Multiple Myeloma Market and Competitive Landscape &#8211; 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-10-06T10:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/"},"wordCount":420,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/","name":"US Multiple Myeloma Market and Competitive Landscape - 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg","datePublished":"2022-10-06T10:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221006005454\/en\/1594125\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/us-multiple-myeloma-market-and-competitive-landscape-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"US Multiple Myeloma Market and Competitive Landscape &#8211; 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49236"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49236\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}